Stock Analiz

Beam Therapeutics Inc. (BEAM) stock forecast and price target

Price $22.83 · data as of November 13, 2026

12-month price target

Average target$49.85
Upside / downside+118.3%
Analysts13
ConsensusStrong buy
Low $26.00Average $49.85High $80.00

Gold marker: average target · white marker: today’s price ($22.83)

Analyst ratings

Strong buy 1Buy 12Hold 2Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-4.53−459.6%$39M
Next fiscal year
ends December 31, 2027
$-5.01−10.6%$31M
Next quarter
ends December 31, 2026
$-1.22−152.4%$6M
Quarter after
ends March 31, 2027
$-1.24−36.3%$400000

Consensus of the analysts covering Beam Therapeutics, updated daily. In the last 30 days 0 estimates were raised and 10 lowered.

Frequently asked questions

What is the Beam Therapeutics stock price target?

The average 12-month target from 13 analysts is $49.85, 118.3% above the current price of $22.83 Targets range from $26.00 to $80.00.

Is Beam Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 12 buy, 2 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Beam Therapeutics expected to earn?

Analysts expect EPS of $-4.53 for the fiscal year ending December 31, 2026 and $-5.01 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.